PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
Acute coronary syndrome (ACS) is a form of coronary heart disease (CHD), combining acute myocardial infarction with ST segment elevation (STE ACS), acute myocardial infarction without ST segment elevation, and unstable angina (non-STE ACS). These clinical forms are considered as one syndrome, due to...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2010-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1440 |
| Summary: | Acute coronary syndrome (ACS) is a form of coronary heart disease (CHD), combining acute myocardial infarction with ST segment elevation (STE ACS), acute myocardial infarction without ST segment elevation, and unstable angina (non-STE ACS). These clinical forms are considered as one syndrome, due to a high risk of acute myocardial infarction and sudden coronary death. Therefore, the problem of ACS treatment is particularly important. The management of non-STE ACS should always include anticoagulants – specifically, enoxaparin or unfractionated heparin. This study was aimed at identifying the anticoagulant with the best clinical and pharmaco-economic characteristics in conservative treatment of non-STE ACS. |
|---|---|
| ISSN: | 1560-4071 2618-7620 |